--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "My Next Med" developer_entity: "Ray Flinkerbusch" bundle_id: "nl.mdg4development.NextMed" app_store_id: "6741319265" category: "Medical" primary_platform: "ios" primary_monetization: "Free" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "2026-08-10" report_date: "2026-10-28" last_verified: "2026-10-28T00:00:00.000Z" report_version: "1.2" total_reviews: 0 confidence: "low" confidence_score: 0.05 data_age_days: 7 momentum_velocity: "maintenance" intelligence_version: 2 tags: ["medical", "free", "mobile app", "app review", "app analysis", "parents", "managing", "children's"] canonical_url: "https://marlvel.ai/apps/my-next-med" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # My Next Med Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Free > **TL;DR:** My Next Med is a medical app by Ray Flinkerbusch, available on iOS. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** My Next Med is a medical app by Ray Flinkerbusch. ## Quick Facts | Fact | Value | | :--- | :--- | | **Category** | Medical | | **Developer** | Ray Flinkerbusch | | **Pricing** | Free | | **Platforms** | iOS | | **Confidence** | Low (0.05/1.0) | | **Data Age** | 7d | ## Metadata & Market Performance - **Publisher:** Ray Flinkerbusch - **Category:** Medical - **Target Audience:** Parents managing children's medications and adult children caring for elderly parents who require structured dosing schedules. - **Platforms:** iOS - **Version Reviewed:** 1.2 - **Report Date:** 2026-10-28 - **Signal Count:** 0 reviews analyzed - **Confidence:** Low (0.05/1.0) - **App Store ID (iOS):** 6741319265 - **Bundle ID:** nl.mdg4development.NextMed - **Data Window:** Analysis based on signals collected up to 2026-10-28 ## Executive Snapshot **What it is:** My Next Med is a medication tracking app for families that provides interval-based scheduling and dose history logging on iOS. **Why users hire it:** The app removes the cognitive load of managing complex dosing schedules for multiple family members by centralizing logs into a single, on-device timeline. ## App DNA (Features & Intent) - **[Differentiator] Multi-User Profiles:** Create and manage separate medication profiles for multiple family members within one account. * *User Intent:* Users seek enhanced value through premium features. - **[Differentiator] Interval Tracking:** Calculates timing between doses and provides scheduling guidance for medication adherence. * *User Intent:* Users seek enhanced value through premium features. - **[Standard] Dose History Timeline:** Logs medication intake with smart filtering to track adherence patterns over time. * *User Intent:* Users want to quickly find relevant content or features. ## Market Position {#market-position} My Next Med occupies a niche in the medical utility category, focusing on manual, privacy-first family tracking. Without a public rating or ranking footprint, the app currently relies on organic discovery rather than chart-driven growth. ## Monetization Strategy - **Model:** Free - **Tiers:** Free access to all current features - **Analysis:** The app is currently free with no visible monetization gates or subscription tiers. ## SWOT Analysis {#swot} **Core Strengths:** - Multi-user profile architecture enables centralized household health management. - Interval-based scheduling logic provides active adherence guidance beyond passive alerts. **Growth Levers:** - Integration with Apple Health would reduce manual entry friction for existing users. ## What's New - **Latest (v1.2, 2 months ago):** Dose logs now appear instantly on the dashboard without requiring a manual refresh. ## App Momentum (Maintenance) {#momentum} - Ships bug fixes at 11-week cadence. - Updated dashboard to reflect logged doses. > **Cadence:** 1 total versions · 0 majors in last 6 months · 79 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} My Next Med is a medical app that is completely free. > **Bottom Line:** My Next Med provides a functional, privacy-focused tool for household medication tracking, but the lack of automated data entry and cloud-sync limits its utility for long-term chronic care. Prioritizing automated database integration would reduce user friction and unlock sustained daily habit formation. **Best for:** Parents managing children's medications and adult children caring for elderly parents who require structured dosing schedules. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Integrate automated medication database search because manual entry is the top friction point → increase daily retention ### Outlook: Stable Users report: The medical utility market is shifting toward automated, integrated health records, leaving manual-entry apps like My Next Med exposed. Without cloud-sync or automated database imports, the app will struggle to retain users managing long-term chronic conditions, which are the highest-value segments for this category. - ⚪ The maintenance-only release cadence suggests a stable feature set rather than an aggressive growth phase. - 🔴 Lack of cloud-sync creates a data-loss risk that will eventually trigger churn as user health records grow. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Total Reviews | 0 | | Confidence | Low | | Pricing Model | Free | | Platforms | iOS | | Key Features | 3 analyzed | | Outlook | Stable | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **My Next Med** (this app) | N/A/5 | N/A | Ray Flinkerbusch | | [BabyMeasure: Growth Tracker](https://marlvel.ai/apps/babymeasure-growth-tracker) | N/A/5 | N/A | Emre HAMURCU | | [Lace Pro](https://marlvel.ai/apps/lace-pro) | 4.6/5 | Excited | Neurotone AI | | [Medical Abbreviations: Quick](https://marlvel.ai/apps/medical-abbreviations-quick) | 4.0/5 | Excited | VLR Software | | [Nursing Home Check](https://marlvel.ai/apps/nursing-home-check) | 4.0/5 | N/A | Alona Nesterenko | | [VetCore: Pet Health Records](https://marlvel.ai/apps/vetcore-pet-health-records) | N/A/5 | N/A | Dmitriy Motorin | ## Company Profile - **Developer:** Ray Flinkerbusch ## Data Sources & Links - **App Store ID:** 6741319265 - **Sources:** App store metadata. ## Related Intel Reports - [*BabyMeasure: Growth Tracker*](https://marlvel.ai/apps/babymeasure-growth-tracker) (Emre HAMURCU) · N/A Rating - [*Lace Pro*](https://marlvel.ai/apps/lace-pro) (Neurotone AI) · 4.6/5 Rating | Positive Sentiment - [*Medical Abbreviations: Quick*](https://marlvel.ai/apps/medical-abbreviations-quick) (VLR Software) · 4.0/5 Rating | Positive Sentiment - [*Nursing Home Check*](https://marlvel.ai/apps/nursing-home-check) (Alona Nesterenko) · 4.0/5 Rating - [*VetCore: Pet Health Records*](https://marlvel.ai/apps/vetcore-pet-health-records) (Dmitriy Motorin) · N/A Rating - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.05/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 0 - **Data Sources:** App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 7 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/my-next-med) Data licensed for AI Agent attribution under CC-BY-NC 4.0.